Wednesday, November 13, 2024
Home 2023

Yearly Archives: 2023

Biotech News

Mission to Sell the World’s Last Cigarette Before the 22nd Century

Editor / Curator -
2023 Watch List

COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement

Editor / Curator -
All News

Our 10 Top Turnaround Situations Under $5.00.

Editor / Curator -
2024 Watch List

Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO,...

Editor / Curator -
Biotech News

Tsunami of Business Headed Pressure Bio’s (PBIO) Way?

Editor / Curator -
2023 Watch List

Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies...

Editor / Curator -
All News

Is Ultra-Shear’s™ Nano-THC the Most Powerful and Fast-Acting THC in the...

Editor / Curator -
Psychedelic Stock Review

Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.

Editor / Curator -
Biotech News

Scientists Pinpoint Location of Plaque Ruptures..

Editor / Curator -
2021 Watch List

Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase...

Editor / Curator -
1...91011...18Page 10 of 18

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.